In vitro activity of new proteasome and immunoproteasome inhibitors on dendritic cell maturation

被引：0
|
作者：
Al-Homsi, A. S. [1 ]
Lai, Z. [1 ]
Roy, T. S. [1 ]
Kouttab, N. [1 ]
机构：
[1] Roger Williams Med Ctr, Providence, RI USA
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S410 / S410
页数：1
相关论文
共 50 条
  • [1] Effect of novel proteasome and immunoproteasome inhibitors on dendritic cell maturation, function, and expression of IκB and NFκB
    Al-Homsi, Ahmad Samer
    Lai, Zhongbin
    Roy, Tara S.
    Kouttab, Nicholas
    [J]. TRANSPLANT IMMUNOLOGY, 2013, 29 (1-4) : 1 - 6
  • [2] Gastric cancer cell types display distinct proteasome/immunoproteasome patterns associated with migration and resistance to proteasome inhibitors
    Francesca Monittola
    Marzia Bianchi
    Maria Gemma Nasoni
    Francesca Luchetti
    Mauro Magnani
    Rita Crinelli
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10085 - 10097
  • [3] Gastric cancer cell types display distinct proteasome/immunoproteasome patterns associated with migration and resistance to proteasome inhibitors
    Monittola, Francesca
    Bianchi, Marzia
    Nasoni, Maria Gemma
    Luchetti, Francesca
    Magnani, Mauro
    Crinelli, Rita
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10085 - 10097
  • [4] Cell-specific inhibition of paramyxovirus maturation by proteasome inhibitors
    Watanabe, H
    Tanaka, Y
    Shimazu, Y
    Sugahara, F
    Kuwayama, M
    Hiramatsu, A
    Kiyotani, K
    Yoshida, T
    Sakaguchi, T
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 2005, 49 (09) : 835 - 844
  • [5] Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib
    Subklewe, Marion
    Sebelin-Wulf, Kathrin
    Beier, Carola
    Lietz, Andreas
    Mathas, Stephan
    Doerken, Bernd
    Pezzutto, Antonio
    [J]. HUMAN IMMUNOLOGY, 2007, 68 (03) : 147 - 155
  • [6] Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)
    Kuhn, D. J.
    Orlowski, R. Z.
    Bjorklund, C. C.
    [J]. CURRENT CANCER DRUG TARGETS, 2011, 11 (03) : 285 - 295
  • [7] Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome
    Culletta, Giulia
    Tutone, Marco
    Ettari, Roberta
    Perricone, Ugo
    Di Chio, Carla
    Almerico, Anna Maria
    Zappala, Maria
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [8] Pronounced up-regulation of the PA28α/β proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation
    Macagno, A
    Kuehn, L
    de Giuli, R
    Groettrup, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (11) : 3271 - 3280
  • [9] A new carboxamide compound exerts immunosuppressive activity by inhibiting dendritic cell maturation
    Carbonnelle, D
    Ebstein, F
    Rabu, C
    Petit, JY
    Gregoire, M
    Lang, F
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (02) : 546 - 556
  • [10] An inhibitor of proteasome β2 sites sensitizes myeloma cells to immunoproteasome inhibitors
    Downey-Kopyscinski, Sondra
    Daily, Ellen W.
    Gautier, Marc
    Bhatt, Ananta
    Florea, Bogdan I.
    Mitsiades, Constantine S.
    Richardson, Paul G.
    Driessen, Christoph
    Overkleeft, Herman S.
    Kisselev, Alexei F.
    [J]. BLOOD ADVANCES, 2018, 2 (19) : 2443 - 2451
12345